ArticleThe Journal of reproduction and development2026
Sperm-TLR2 activation enhances bovine embryo developmental competence via modulation of intracellular calcium and autophagic flux.
Article in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sperm TLR2/1 activation modulates the paternal RNA cargo and enhances bovine embryonic development.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The optimization of in vitro embryo production (IVP) is critical for bovine biotechnology, particularly for maximizing the yield of high-quality embryos suitable for transfer. This study investigated how Toll-like receptor 2 (TLR2) activation in sperm, using the agonist Pam3CSK4 (Pam), influences fertilization outcomes, metabolic activity, and cryotolerance. Japanese Black sperm were treated with 50 ng/ml Pam for 30 min before fertilizing Holstein oocytes. Embryos were cultured for 7 days, with quality assessed via total cell counts, apoptosis, calcium signaling, and autophagy markers. For cryopreservation trials, only high-quality (grade A) blastocysts were selected for slow-freezing to evaluate re-expansion and hatching rates. Our results demonstrate that TLR2 activation in sperm significantly enhanced cleavage and blastocyst rates, increasing the overall efficiency of embryo production by approximately 10% compared to the control. Embryos derived from Pam-treated sperm exhibited superior biological quality, characterized by increased total cell numbers in blastocysts and reduced apoptosis in expanded blastocysts. Mechanistically, TLR2 activation elevated basal calcium levels and modulated autophagic flux, indicating a beneficial shift in metabolic programming. Notably, while the absolute number of embryos increased, the proportion of grade A blastocysts and their post-thaw survival metrics remained comparable to the control. This suggests that while TLR2 signaling effectively scales up IVP efficiency, the resulting developmental gains represent a hidden physiological strength that conventional morphological grading may not fully capture. These findings indicate that pre-IVF sperm treatment with Pam effectively primes the embryo for superior cellular development while maintaining the essential cryo-survival standards required for commercial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.